Annexon (ANNX) Projected to Post Earnings on Tuesday

Annexon (NASDAQ:ANNX) will likely be issuing its quarterly earnings data before the market opens on Tuesday, March 25th. Analysts expect the company to announce earnings of ($0.28) per share for the quarter.

Annexon (NASDAQ:ANNX) last released its quarterly earnings data on Monday, March 3rd. The company reported ($0.33) earnings per share for the quarter, missing the consensus estimate of ($0.28) by ($0.05). On average, analysts expect Annexon to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

Annexon Stock Down 3.6 %

Shares of NASDAQ:ANNX opened at $2.40 on Monday. The firm has a fifty day moving average of $3.25 and a two-hundred day moving average of $5.10. Annexon has a 12-month low of $2.30 and a 12-month high of $8.40. The firm has a market capitalization of $263.30 million, a P/E ratio of -2.29 and a beta of 1.14.

Wall Street Analysts Forecast Growth

A number of analysts recently issued reports on the company. HC Wainwright reissued a “buy” rating and set a $30.00 price objective on shares of Annexon in a research report on Tuesday, December 17th. Needham & Company LLC reiterated a “buy” rating and set a $16.00 price target on shares of Annexon in a report on Tuesday, March 4th. Six research analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the company currently has an average rating of “Buy” and an average target price of $15.80.

About Annexon

Annexon, Inc, a clinical-stage biopharmaceutical company, discovers and develops medicines for treating inflammatory-related diseases. Its lead candidate is ANX005, an investigational full-length monoclonal antibody, which is in Phase 3 clinical trial for the treatment of patients with guillain-barré syndrome; completed Phase II clinical trial for treating Huntington's disease; and in Phase II clinical trial for the treatment of amyotrophic lateral sclerosis.